glp-1 blog Taking a Break from GLP-1: What You Need to Know Exploring the Neurological Questions Surrounding

They could be a sign of an underlying condition that needs treatment

doi: 10.3390/ijms23169340, 23

California Association of DUI Treatment Centers (CADTP) This educational program is approved by CADTP: #205

Qualifying Comorbidities FDA labeling and clinical guidelines commonly recognize: Hypertension (blood pressure 130/80 or taking antihypertensive medication) Type 2 diabetes (HbA1c 6.5% or on glucose-lowering medication) Prediabetes (HbA1c 5.7-6.4% or impaired fasting glucose) Dyslipidemia (elevated LDL, low HDL, or elevated triglycerides) Obstructive sleep apnea (diagnosed via sleep study) Cardiovascular disease (prior MI, stroke, coronary artery disease) Non-alcoholic fatty liver disease / MASLD Polycystic ovary syndrome (PCOS) with metabolic features Osteoarthritis weight-bearing joints Insurance formularies may be stricter some require objective documentation (lab values, sleep study reports) rather than self-report

Heres what I actually pay attention to when Im testing something like a GLP-1-style patch: Cravings timing: Do cravings hit at the same time every day